Fundamental Analysis of Eli Lilly and Company - Growth / Value Index


LLY - Valuation Highlights

Valuation Analysis

   Undervalued - Price to Intrinsic Value of 0.636
   Book Value in last 3 years is trending up
   Tsr Value Index - Very Poor Score of 7.81
   Price to Earning Ratio is 110.25 and EV to EBITDA is 264.46 suggesting that it is very expensive
   Price to Book Ratio of 58.83 suggesting that it is very expensive
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 111.12 139.43 25.00 %
Price to Book 59.30 64.02 -0.959 % 53.96
Price to Sales 18.98 21.69 -11.14 %
Enterprise Value to EBITDA Multiple 266.48 62.82 -28.76 %


LLY - Profitability Highlights

Profitability Analysis

   Over the last 3 years, the company has achieved Incredible Return on Equity
   Company Earning excess return
   During the past twelve months, the company has given a strong Return On Equity of 53.79%
   Company's Net Profit is increasing for last 5 Quarters
   Company's Profit Before Tax is increasing for last 5 Quarters
   EBITDA is continuously increasing for last 3 Years
   Steady Growth in EPS for last four quarters
   Good Return On Capital Employed of 14.56
   Good Net Margin of 17.08% is achieved by the company
   Very Low Dividend Yield of 0.680 %
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 53.79 46.31 -21.02 % 17.51
Return On Asset 10.45 7.79 -38.24 % 3.51
Net Profit Margin 17.08 15.55 -28.91 % 25.58
Operating Profit Margin 4.87 30.91 6.55 % 29.88
EBITDA Margin 7.88 35.63 26.18 % 36.62


Highlights
Market Cap731811 M
Enterprise Value754218 M
Price/Book TTM59.30
Outstanding Share950404 K
Float/ Outstanding Share94.50%
Dividend Yield0.670 %
Share Holding
Guru Numbers
Price/Graham No17.78
Peter Lynch Ratio-0.180
Piotroski F Score6.00
Altman Z Score9.47
Sloan Ratio0.100
Peter Lynch Fair Value104.09


LLY - Growth Highlights

Growth Analysis

   Annual sales of the company is increased for three years in a row
   Steady increase in Total Assets for last 3 Years
   Tsr Growth Index - Very Poor Score of 17.66
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 35932.10 M 12.37 % 6.26 %
Gross Profit 19572.60 M 15.15 % 5.99 %
EBITDA 2830.30 M 41.79 % 10.90 %
Net Profit 6138.40 M 20.12 % 2.43 %
EPS 6.93 20.00 % NA


LLY - Stability Highlights

Stability Analysis

   Altman Z Score of 9.41 suggests good Stability
   Company has high debt burden
   Company is unable to generate enough free cash to support the business.
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 2.34 53.58 % 2.05
Cash Ratio 0.107 -16.88 %
Quick Ratio 0.731 -8.71 % 1.03
Shareholders Equity 16.83 -21.79 %
Debt to EBITDA 2.21 9.56 %


Historical Valuation Ratios of Eli Lilly and Company

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Eli Lilly and Company

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Eli Lilly and Company

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Eli Lilly and Company

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)